Ascletis’ ASC37 Shows Strong Weight Loss Results i...
Category : Clinical Trial Update 28 July 2026Next-generation triple peptide agonist outperformed tirzepatide in obese mice Ascletis Pharma Inc...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Next-generation triple peptide agonist outperformed tirzepatide in obese mice Ascletis Pharma Inc...
Nuzolvence becomes a new oral antibiotic option for uncomplicated urogenital gonorrhea Dr. Reddy&...
Ubeslo and Evlarco move closer to potential approval for patients with high LDL-C NewAmsterdam Ph...
Deal to strengthen Apitoria Pharma’s move toward a CRDMO platform Aurobindo Pharma Limited...
Deal will add manufacturing capacity in skincare, wellness, hair care and colour cosmetics Akums...